k slab agent tumor OR PFS OS ncoh-OR ncoh-PFS ncoh-OS npat-OR npat-PFS npat-OS nresp-OR nresp-PFS nresp-OS npat
1                                Migden Rischin 2020              cemiplimab                       other                            1                                0                                0                                1                                0                                0                                48                               0                                0                                48                               0                                0                                48                              
2                                Nowak Stockler 2020              durvalumab                       other                            0                                1                                0                                0                                1                                0                                0                                51                               0                                0                                51                               0                                51                              
3                                Domchek Kaufman 2020             durvalumab                       breast                           0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
4                                Kelly Ku 2020                    durvalumab                       other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
5                                Chia Seymour 2019                durvalumab                       breast                           0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
6                                Zimmer Lee 2019                  durvalumab                       other                            1                                0                                0                                1                                0                                0                                9                                0                                0                                9                                0                                0                                9                               
7                                Antonia Segal 2019               durvalumab                       NSCLC                            1                                1                                1                                1                                1                                1                                256                              256                              256                              256                              256                              256                              256                             
8                                Thomas Lee 2019                  durvalumab                       other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
9                                Vaishampayan Gulley 2019         avelumab                         other                            1                                1                                0                                1                                1                                0                                41                               41                               0                                41                               41                               0                                41                              
10                               Konstantinopoulos Matulonis 2019 avelumab                         other                            1                                0                                0                                2                                0                                0                                31                               0                                0                                56                               0                                0                                31                              
11                               Mego Mardiak 2019                avelumab                         other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
12                               Doi Watanabe 2019                avelumab                         other                            1                                1                                0                                1                                1                                0                                38                               38                               0                                38                               38                               0                                38                              
13                               Markovic Anderson 2020           ipilimumab                       melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
14                               Welsh Hong 2019                  ipilimumab                       other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
15                               Schadendorf Nathan 2019          nivolumab                        melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
16                               Kanda Tamura 2020                nivolumab                        NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
17                               Kato Kitagawa 2020               nivolumab                        other                            1                                0                                0                                2                                0                                0                                38                               0                                0                                75                               0                                0                                38                              
18                               Felip Popat 2020                 nivolumab                        NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
19                               Nomura Andoh 2020                nivolumab                        melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
20                               Santin Birrer 2020               nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
21                               Azad Flaherty 2020               nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
22                               Sudo Ochiya 2020                 nivolumab                        other                            1                                0                                0                                1                                0                                0                                15                               0                                0                                15                               0                                0                                15                              
23                               Naing Tannir 2019                pembrolizumab or nivolumab       other                            1                                0                                0                                1                                0                                0                                21                               0                                0                                21                               0                                0                                21                              
24                               Morse El-Rayes 2019              ipilimumab/nivolumab             other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
25                               Naumann Moore 2019               nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
26                               Doi Yamamoto 2019                nivolumab                        other                            1                                0                                0                                6                                0                                0                                15                               0                                0                                74                               0                                0                                15                              
27                               Tamura Minami 2019               nivolumab                        other                            1                                1                                0                                4                                4                                0                                22                               22                               0                                75                               75                               0                                22                              
28                               Carneiro Giles 2019              nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
29                               Ohyama Kimura 2019               nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
30                               Flippot Albiges 2019             nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
31                               Fujimoto Tomii 2019              nivolumab                        NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
32                               Ueno Furuse 2019                 nivolumab                        other                            1                                0                                0                                2                                0                                0                                29                               0                                0                                57                               0                                0                                29                              
33                               Ma Zhang 2019                    nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
34                               Sundahl Ost 2019                 nivolumab                        melanoma                         1                                0                                0                                1                                0                                0                                20                               0                                0                                20                               0                                0                                20                              
35                               Marabelle Bang 2020              pembrolizumab                    other                            1                                0                                0                                5                                0                                0                                790                              0                                0                                2327                             0                                0                                790                             
36                               Yau Kudo 2019                    nivolumab                        other                            1                                0                                0                                1                                0                                0                                162                              0                                0                                162                              0                                0                                162                             
37                               Catenacci Group 2020             pembrolizumab                    other                            1                                1                                1                                2                                2                                1                                92                               92                               92                               168                              168                              92                               92                              
38                               Kawazoe Shitara 2020             pembrolizumab                    other                            1                                1                                0                                2                                2                                0                                29                               29                               0                                50                               50                               0                                29                              
39                               Brastianos Sullivan 2020         pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
40                               Bockorny Hidalgo 2020            pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
41                               Janjigian Hechtman 2020          pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
42                               Goldberg Kluger 2020             pembrolizumab                    NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
43                               Middleton Billingham 2020        pembrolizumab                    NSCLC                            1                                0                                0                                1                                0                                0                                57                               0                                0                                57                               0                                0                                57                              
44                               Kawazoe Shitara 2020             pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                54                               0                                0                                54                               0                                0                                54                              
45                               Färkkilä Konstantinopoulos 2020  pembrolizumab                    other                            1                                1                                0                                2                                1                                0                                50                               50                               0                                76                               50                               0                                50                              
46                               Shah Gradishar 2020              pembrolizumab                    breast                           0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
47                               Nishio Ushijima 2020             pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                8                                0                                0                                8                                0                                0                                8                               
48                               Rodriguez Martins 2020           pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
49                               Antonarakis Bono 2020            pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                143                              0                                0                                143                              0                                0                                143                             
50                               Ho McArthur 2020                 pembrolizumab                    breast                           0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
51                               Le André 2020                    pembrolizumab                    other                            1                                0                                0                                4                                0                                0                                41                               0                                0                                150                              0                                0                                41                              
52                               Mahalingam Fountzilas 2020       pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
53                               Marabelle Jr 2020                pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
54                               Raj Reidy-Lagunes 2020           pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                34                               0                                0                                34                               0                                0                                34                              
55                               Habra Naing 2019                 pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
56                               Kim Heo 2019                     pembrolizumab                    other                            0                                1                                0                                0                                2                                0                                0                                NA                               0                                0                                NA                               0                                0                               
57                               Cesne Italiano 2019              pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
58                               Gray Beg 2019                    pembrolizumab                    NSCLC                            0                                1                                1                                0                                1                                1                                0                                23                               23                               0                                23                               23                               23                              
59                               Herbst Chau 2019                 pembrolizumab                    other                            0                                0                                1                                0                                0                                1                                0                                0                                39                               0                                0                                39                               39                              
60                               Feun Savaraj 2019                pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                10                               0                                0                                10                               0                                0                                10                              
61                               Garon Hui 2019                   pembrolizumab                    NSCLC                            1                                0                                0                                1                                0                                0                                487                              0                                0                                487                              0                                0                                487                             
62                               Nathan Schadendorf 2019          nivolumab                        melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
63                               Matulonis Ledermann 2019         pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                420                              0                                0                                420                              0                                0                                420                             
64                               Cho Ahn 2019                     pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                24                               0                                0                                24                               0                                0                                24                              
65                               Bang Chung 2019                  pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
66                               Terranova-Barberio Munster 2020  pembrolizumab                    breast                           0                                1                                1                                0                                1                                1                                0                                NA                               NA                               0                                NA                               NA                               0                               
67                               Chalmers Akerley 2019            ipilimumab                       NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
68                               Emens Loi 2020                   atezolizumab                     breast                           1                                0                                0                                2                                0                                0                                132                              0                                0                                209                              0                                0                                132                             
69                               Lee investigators 2020           atezolizumab                     other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
70                               Shemesh Girish 2019              atezolizumab                     other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
71                               McGregor Choueiri 2020           atezolizumab                     other                            1                                0                                0                                1                                0                                0                                36                               0                                0                                36                               0                                0                                36                              
72                               Fehlings Yadav 2019              atezolizumab                     NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
73                               Hamid Hodi 2019                  atezolizumab                     melanoma                         1                                1                                1                                2                                2                                3                                39                               39                               39                               78                               62                               101                              39                              
74                               Liu Emens 2019                   atezolizumab                     other                            1                                0                                0                                2                                0                                0                                15                               0                                0                                23                               0                                0                                15                              
75                               Hellmann Bendell 2019            atezolizumab                     other                            1                                0                                0                                2                                0                                0                                63                               0                                0                                83                               0                                0                                63                              
76                               Migden Fury 2018                 cemiplimab                       other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
77                               Adra Hanna 2018                  pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                12                               0                                0                                12                               0                                0                                12                              
78                               Garassino Rizvi 2018             durvalumab                       NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
79                               Duarte Cebon 2018                ipilimumab                       melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
80                               Callahan Sznol 2018              ipilimumab/nivolumab             melanoma                         1                                0                                0                                1                                0                                0                                37                               0                                0                                37                               0                                0                                37                              
81                               Fuchs Yoon 2018                  pembrolizumab                    other                            1                                0                                0                                2                                0                                0                                257                              0                                0                                431                              0                                0                                257                             
82                               Mehra Haddad 2018                pembrolizumab                    other                            1                                1                                0                                1                                1                                0                                192                              188                              0                                192                              188                              0                                192                             
83                               Zhu Kudo 2018                    pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
84                               Ariyan Allison 2018              ipilimumab                       melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
85                               Wrangle Rubinstein 2018          nivolumab                        NSCLC                            1                                0                                0                                1                                0                                0                                16                               0                                0                                16                               0                                0                                16                              
86                               Quispel-Janssen Baas 2018        nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
87                               Atkins Choueiri 2018             pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                43                               0                                0                                43                               0                                0                                43                              
88                               Choueiri Rini 2018               avelumab                         other                            1                                0                                0                                1                                0                                0                                52                               0                                0                                52                               0                                0                                52                              
89                               Chesney Kaufman 2018             ipilimumab                       melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
90                               McDermott Powles 2018            atezolizumab                     other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
91                               Haag Jaeger 2018                 ipilimumab                       melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
92                               Galsky Uzilov 2018               ipilimumab                       other                            1                                0                                0                                1                                0                                0                                28                               0                                0                                28                               0                                0                                28                              
93                               Luke Chmura 2018                 pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
94                               Robert Hodi 2018                 pembrolizumab                    melanoma                         1                                0                                0                                2                                0                                0                                649                              0                                0                                1158                             0                                0                                649                             
95                               Giaccone McCutcheon 2018         pembrolizumab                    other                            1                                1                                1                                1                                1                                2                                37                               37                               37                               37                               37                               64                               37                              
96                               Lisberg Garon 2018               pembrolizumab                    NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
97                               Doi Bennouna 2018                pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
98                               Toulmonde Italiano 2018          pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
99                               Weiss Khemka 2018                pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
100                              Arkenau Chau 2018                pembrolizumab                    other                            0                                1                                1                                0                                1                                1                                0                                24                               24                               0                                24                               24                               24                              
101                              Rugo Tan 2018                    pembrolizumab                    breast                           0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
102                              Tahara Bang 2018                 pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
103                              Atkins Ribas 2018                pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
104                              Petrylak Vogelzang 2018          atezolizumab                     other                            0                                1                                1                                0                                1                                1                                0                                94                               94                               0                                94                               94                               94                              
105                              Long McArthur 2018               ipilimumab/nivolumab             melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
106                              D'Angelo Streicher 2018          ipilimumab/nivolumab             other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
107                              Ma Chan 2018                     nivolumab                        other                            1                                0                                0                                1                                0                                0                                41                               0                                0                                41                               0                                0                                41                              
108                              Gettinger Rizvi 2018             nivolumab                        NSCLC                            1                                0                                0                                1                                0                                0                                15                               0                                0                                15                               0                                0                                15                              
109                              Spigel Jr 2018                   nivolumab                        NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
110                              Lee Park 2018                    nivolumab                        NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
111                              Sullivan Hwu 2019                atezolizumab                     melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
112                              Amin Hammers 2018                nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
113                              Yamazaki Minami 2019             nivolumab                        melanoma                         1                                1                                1                                2                                2                                2                                23                               24                               24                               40                               41                               41                               24                              
114                              Levy Paz-Ares 2019               pembrolizumab                    NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
115                              Lukas Baehring 2018              atezolizumab                     other                            0                                1                                1                                0                                1                                1                                0                                12                               12                               0                                12                               12                               12                              
116                              Wilky Trent 2019                 pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
117                              Massarelli Glisson 2019          nivolumab                        other                            1                                0                                0                                1                                0                                0                                18                               0                                0                                18                               0                                0                                18                              
118                              Horn Soria 2018                  atezolizumab                     NSCLC                            1                                0                                1                                2                                0                                2                                65                               0                                65                               116                              0                                116                              65                              
119                              Disselhorst Baas 2019            ipilimumab/nivolumab             other                            1                                0                                0                                1                                0                                0                                34                               0                                0                                34                               0                                0                                34                              
120                              Parikh Jr 2018                   pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
121                              Gibney Weber 2019                ipilimumab                       melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
122                              Keilholz Gulley 2019             avelumab                         melanoma                         1                                1                                1                                1                                1                                1                                39                               39                               39                               39                               39                               39                               39                              
123                              Ornstein Rini 2019               nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
124                              Ready Ramalingam 2019            ipilimumab/nivolumab             NSCLC                            1                                1                                0                                2                                2                                0                                252                              252                              0                                350                              350                              0                                252                             
125                              Chung Leary 2019                 pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                96                               0                                0                                96                               0                                0                                96                              
126                              Makker Taylor 2019               pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                24                               0                                0                                24                               0                                0                                24                              
127                              Hamid Ribas 2019                 pembrolizumab                    melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
128                              Shah Kato 2019                   pembrolizumab                    other                            1                                1                                1                                1                                1                                1                                121                              121                              121                              121                              121                              121                              121                             
129                              Ascierto Ribas 2019              pembrolizumab                    melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
130                              Kim Kang 2018                    pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                55                               0                                0                                55                               0                                0                                55                              
131                              Ott Lunceford 2019               pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
132                              Adams Cortés 2019                pembrolizumab                    breast                           1                                1                                1                                1                                1                                1                                169                              169                              169                              169                              169                              169                              169                             
133                              Ribas Hamid 2019                 pembrolizumab                    melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
134                              Leighl Garon 2019                pembrolizumab                    NSCLC                            1                                0                                0                                1                                0                                0                                396                              0                                0                                396                              0                                0                                396                             
135                              Gadgeel Papadimitrakopoulou 2018 pembrolizumab                    NSCLC                            1                                0                                0                                3                                0                                0                                25                               0                                0                                73                               0                                0                                25                              
136                              Adams Schmid 2019                pembrolizumab                    breast                           0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
137                              Loi Group 2019                   pembrolizumab                    breast                           1                                1                                1                                1                                1                                1                                27                               58                               58                               27                               58                               58                               58                              
138                              Mehnert Keam 2019                pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
139                              Nghiem Topalian 2019             pembrolizumab                    other                            1                                0                                0                                1                                0                                0                                47                               0                                0                                47                               0                                0                                47                              
140                              Varga Matei 2019                 pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
141                              Ribas Janssen 2018               pembrolizumab                    melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
142                              Gadgeel Kalemkerian 2018         pembrolizumab                    other                            0                                1                                1                                0                                1                                1                                0                                20                               20                               0                                20                               20                               20                              
143                              Yang Patnaik 2019                pembrolizumab                    NSCLC                            1                                0                                0                                2                                0                                0                                12                               0                                0                                19                               0                                0                                12                              
144                              Maity Vonderheide 2018           pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
145                              Nishio Kato 2019                 pembrolizumab                    NSCLC                            1                                0                                0                                1                                0                                0                                48                               0                                0                                48                               0                                0                                48                              
146                              Sundar Tan 2019                  pembrolizumab-or-nivolumab       other                            1                                1                                0                                1                                1                                0                                37                               37                               0                                37                               37                               0                                37                              
147                              Gubens Gandhi 2019               ipilimumab/pembrolizumab         NSCLC                            1                                0                                0                                1                                0                                0                                44                               0                                0                                44                               0                                0                                44                              
148                              Chung Diamond 2019               pembrolizumab                    other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
149                              Adams Powderly 2019              atezolizumab                     breast                           1                                1                                1                                1                                1                                1                                24                               24                               24                               24                               24                               24                               24                              
150                              Emens Schmid 2019                atezolizumab                     breast                           1                                0                                1                                1                                0                                1                                112                              0                                112                              112                              0                                112                              112                             
151                              Colevas Powderly 2018            atezolizumab                     other                            1                                0                                0                                1                                0                                0                                32                               0                                0                                32                               0                                0                                32                              
152                              Jung Davis 2019                  atezolizumab                     other                            1                                0                                0                                1                                0                                0                                59                               0                                0                                59                               0                                0                                59                              
153                              Pujol Souquet 2019               atezolizumab                     NSCLC                            0                                1                                1                                0                                1                                1                                0                                55                               55                               0                                55                               55                               55                              
154                              Liu Powderly 2018                atezolizumab                     NSCLC                            1                                1                                1                                1                                1                                1                                48                               48                               48                               48                               48                               48                               48                              
155                              Spigel Rizvi 2018                atezolizumab                     NSCLC                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
156                              Janjigian Le 2018                nivolumab                        other                            1                                1                                1                                1                                1                                1                                384                              384                              384                              384                              384                              384                              384                             
157                              Tawbi Margolin 2018              nivolumab                        melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
158                              Boku Kang 2019                   nivolumab                        other                            1                                0                                0                                2                                0                                0                                21                               0                                0                                38                               0                                0                                21                              
159                              Sharma Rosenberg 2019            nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
160                              Katsuya Ohe 2019                 nivolumab                        other                            0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
161                              Tarhini Kirkwood 2019            ipilimumab                       melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
162                              Patel Apolo 2018                 avelumab                         melanoma                         1                                1                                1                                1                                1                                1                                322                              206                              206                              322                              206                              206                              322                             
163                              Dirix Hamilton 2018              avelumab                         breast                           1                                0                                0                                4                                0                                0                                136                              0                                0                                544                              0                                0                                136                             
164                              Kaufman Nghiem 2018              avelumab                         other                            1                                0                                0                                1                                0                                0                                74                               0                                0                                74                               0                                0                                74                              
165                              Hassan Gulley 2019               avelumab                         other                            1                                1                                0                                1                                1                                0                                43                               18                               0                                43                               18                               0                                43                              
166                              Tourneau Gulley 2018             avelumab                         other                            1                                1                                0                                1                                1                                0                                42                               42                               0                                42                               42                               0                                42                              
167                              Doi Watanabe 2019                avelumab                         other                            1                                1                                0                                1                                1                                0                                38                               38                               0                                38                               38                               0                                38                              
168                              Siu Fayette 2019                 durvalumab                       other                            1                                0                                0                                4                                0                                0                                129                              0                                0                                388                              0                                0                                129                             
169                              Calabrò Maio 2018                durvalumab                       other                            1                                1                                0                                1                                1                                0                                38                               38                               0                                38                               38                               0                                38                              
170                              Segal Butler 2019                durvalumab                       other                            1                                1                                1                                2                                2                                1                                59                               59                               59                               109                              109                              59                               59                              
171                              Hong Borazanci                   durvalumab                       other                            1                                0                                0                                1                                0                                0                                99                               0                                0                                99                               0                                0                                99                              
172                              Zandberg Mesía 2019              durvalumab                       other                            1                                1                                1                                1                                1                                1                                99                               99                               99                               99                               99                               99                               99                              
173                              Giacomo Maio 2019                ipilimumab                       melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
174                              Chesney Mehnert 2019             ipilimumab                       melanoma                         0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                                0                               
